Beautiful young woman relaxing at park during autumn season with closed eyes. Happy free natural girl breathing deeply in park with foliage in background. Pretty woman expressing freedom outdoor.

Accord BioPharma’s Stelara® Biosimilar Imuldosa™ Approved by FDA

Start
On October 10, 2024, the FDA approved Accord BioPharma’s Imuldosa™ (ustekinumab-srlf), the fifth biosimilar of Janssen / Johnson & Johnson’s Stelara® (ustekinumab). Imuldosa™ was developed by Dong-A ST in collaboration with Meij Seika Pharma, and Accord is responsible for commercialization in the U.S….
By: Venable LLP
Previous Story

Worker’s Comp Versus Personal Injury in California

Next Story

Teva’s Denosumab Biosimilar Candidate is Accepted for Review by FDA and EMA